Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on unselected moderate asthmatics showed that tiotropium was as effective as salmeterol ...

but the new formulation will allow patients to take greater control of their treatment. Like its predecessor, it is approved in the EU for use in patients 12 years and older with severe asthma who ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

New grant funding awarded to a research collaboration from the Brigham and Women’s Hospital and the Boston-based Wyss Institute will push forward research to determine how best to identify what those ...